← Leaderboards
Frederick Simmons Buckner
University Of Washington
$14,937,505
Attributed
$27,343,920
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,343,920 · 8
By mechanism
R01$25,819,360 · 7
P01$1,524,560 · 1
Top collaborators
- Michael H Gelb22 shared
- Erkang Fan12 shared
- Wesley C Van Voorhis7 shared
- Christophe L.M.J. Verlinde7 shared
- Richard R Tidwell4 shared
Most similar at University Of Washington
Same institution · by research overlap
- Michael H Gelb$24,827,130
- Wesley C Van Voorhis$32,631,211
- Erkang Fan$6,366,172
- Christophe L.m.j. Verlinde$963,803
- Wilhelmus G. J. Hol$41,011,333
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsAnalogTrypanosoma CruziDesignParasitesPharmaceutical ChemistryToxic EffectLeadDrug DiscoveryDrug KineticsPre-ClinicalMammalian CellChagas DiseaseInfectionIn VitroOralPropertyDoseSeriesNovel TherapeuticsAfrican TrypanosomiasisMetabolicBaseCytotoxicity
Grant awards (45)
Drug Discovery for Chagas Disease$839,338
R01 · FY2025 · AI · contact PI
Drug Discovery for Chagas Disease$839,338
R01 · FY2024 · AI · contact PI
Developing methionyl tRNA synthetase inhibitors as therapeutics for Chagas disease$814,270
R01 · FY2023 · AI
Drug Discovery for Chagas Disease$837,654
R01 · FY2022 · AI · contact PI
Developing methionyl tRNA synthetase inhibitors as therapeutics for Chagas disease$772,120
R01 · FY2022 · AI
Drug Discovery for Chagas Disease$835,017
R01 · FY2021 · AI · contact PI
Developing methionyl tRNA synthetase inhibitors as therapeutics for Chagas disease$733,618
R01 · FY2021 · AI
Drug Discovery for Chagas Disease$834,220
R01 · FY2020 · AI · contact PI
Developing methionyl tRNA synthetase inhibitors as therapeutics for Chagas disease$733,618
R01 · FY2020 · AI
Drug Discovery for Chagas Disease$833,981
R01 · FY2019 · AI · contact PI
Optimization of methionyl-tRNA synthetase inhibitors for human African trypanosomiasis$696,541
R01 · FY2019 · AI
Optimization of methionyl-tRNA synthetase inhibitors for human African trypanosomiasis$698,131
R01 · FY2018 · AI
Drug Discovery for Human African Trypanosomiasis$784,716
R01 · FY2017 · AI
Optimization of methionyl-tRNA synthetase inhibitors for human African trypanosomiasis$709,649
R01 · FY2017 · AI
Drug Discovery for Human African Trypanosomiasis$776,118
R01 · FY2016 · AI
Optimization of methionyl-tRNA synthetase inhibitors for human African trypanosomiasis$735,148
R01 · FY2016 · AI
Drug Discovery for Human African Trypanosomiasis$719,679
R01 · FY2015 · AI
Structure-based Optimization of T. brucei methionyl tRNA Synthetase Inhibitors$611,718
R01 · FY2015 · AI
Drug Discovery for Human African Trypanosomiasis$719,679
R01 · FY2014 · AI
Structure-based Optimization of T. brucei methionyl tRNA Synthetase Inhibitors$634,893
R01 · FY2014 · AI
Rational development of anti-Trypanosoma cruzi drugs$491,103
R01 · FY2014 · AI · contact PI
Drug Discovery for Human African Trypanosomiasis$689,303
R01 · FY2013 · AI
Structure-based Optimization of T. brucei methionyl tRNA Synthetase Inhibitors$596,800
R01 · FY2013 · AI
Rational development of anti-Trypanosoma cruzi drugs$475,571
R01 · FY2013 · AI · contact PI
Biochemistry of Protein Prenylation$611,813
R01 · FY2012 · AI
Structure-based Optimization of T. brucei methionyl tRNA Synthetase Inhibitors$611,388
R01 · FY2012 · AI
Rational development of anti-Trypanosoma cruzi drugs$552,036
R01 · FY2012 · AI · contact PI
Biochemistry of Protein Prenylation$613,376
R01 · FY2011 · AI
Rational development of anti-Trypanosoma cruzi drugs$537,055
R01 · FY2011 · AI · contact PI
Biochemistry of Protein Prenylation$619,554
R01 · FY2010 · AI
Biochemistry of Protein Prenylation$37,986
R01 · FY2010 · AI
Biochemistry of Protein Prenylation$609,576
R01 · FY2009 · AI
Rational Development of Anti-Trypanosoma Cruzi Drugs$589,661
R01 · FY2009 · AI · contact PI
Biochemistry of Protein Prenylation$64,992
R01 · FY2009 · AI
Biochemistry of Protein Prenylation$597,282
R01 · FY2008 · AI
Rational Development of Anti-Trypanosoma Cruzi Drugs$572,486
R01 · FY2008 · AI · contact PI
Target Selection and Ligand Discovery$522,137
P01 · FY2008 · AI · contact PI
Rational Development of Anti-Trypanosoma Cruzi Drugs$566,580
R01 · FY2007 · AI · contact PI
Target Selection and Ligand Discovery$516,831
P01 · FY2007 · AI · contact PI
Rational Development of Anti-Trypanosoma Cruzi Drugs$578,912
R01 · FY2006 · AI · contact PI
Target Selection and Ligand Discovery$485,592
P01 · FY2006 · AI · contact PI
Sterol Biosynthesis in Trypanosomatid Parasites$317,360
R01 · FY2004 · AI
Sterol Biosynthesis in Trypanosomatid Parasites$317,360
R01 · FY2003 · AI
Sterol Biosynthesis in Trypanosomatid Parasites$317,360
R01 · FY2002 · AI
Sterol Biosynthesis in Trypanosomatid Parasites$292,360
R01 · FY2001 · AI